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Abstract
Background: Asthma is a serious global health problem and its prevalence is increasing, especially
among children. It represents a significant social and economic burden, and it can severely affect
the health-related quality of life (HRQL) of patients. Among the numerous questionnaires aiming
at evaluating asthma HRQL in children, the Pediatric Asthma Quality of Life Questionnaire
(PAQLQ) has proved to have good measurement properties.
The present study was aimed at investigating the possible role of the Italian, self-administered
version of the PAQLQ in the routine clinical evaluation of children affected by bronchial asthma.
Methods: 52 Italian children and adolescents (40 males and 12 females), aged 6 to 17 years,
affected by allergic asthma, were enrolled. Each patient was evaluated twice, and at each visit
asthma control and severity were assessed, spirometry was performed and the patients completed
the self-administered version of the PAQLQ.
Results: The questionnaire was well-accepted and understood by the children. Children showed
an overall good quality of life, with mild impairment in the activity and emotional function domains.
The PAQLQ showed an overall good correlation with the clinical and functional indexes that are
normally evaluated in follow-up visits of asthmatic patients. The PAQLQ appeared to be strongly
related to asthma control, both at the first (p < 0.01) and second (p < 0.001) time of the study. The
PAQLQ was also seen to decrease with increasing asthma severity. The results suggest a better
compliance of the children towards completion of the questionnaire at t1. Finally, the PAQLQ does
not appear to discriminate HRQL in patients with good lung function.
Conclusion: The Italian version of the PAQLQ is a quick-to-administer aid to clinical activity and
can add valuable information to symptom reports, objective measurements and clinical assessment
of asthma control and severity in daily clinical practice. Re-administration at each follow-up visit
allows HRQL to be monitored over time.
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Background
The role of the evaluation of patients' health-related qual-
ity of life (HRQL) has gained importance since 1948,
when the World Health Organization defined health as
being not only the absence of disease and infirmity, but
also the presence of physical, mental and social well-being
[1,2]. HRQL measurement is therefore a multidimen-
sional assessment and it usually includes physical func-
tioning and somatic sensation, as well as social and
emotional functioning and well-being [3,4]. The most
famous definition of quality of life is the one by Schipper
et al. [5]: "Quality of life in clinical medicine represents
the functional effect of an illness and its consequent ther-
apy upon a patient, as perceived by the patient". The inter-
est in considering HRQL as an important tool for a
thorough comprehension of the child's health is increas-
ing, as demonstrated by the recent publication of a survey
on almost 70.000 children to evaluate HRQL in the pedi-
atric population of the United States [6].
Asthma is the most common chronic disease in childhood
in nearly all industrialized countries [7], seriously interfer-
ing with patients' HRQL [8] and imposing a huge burden
on the patients, their families and society [9,10]. Pediatric
asthma accounts for a large proportion of childhood hos-
pitalizations, healthcare visits, absenteeism from day
care/school and missed work days by parents [11]. The
more severe the asthma, the worse the patient's HRQL
seems to be [12]. However, even mild asthmatics suffer on
account of their condition: the level of anxiety has been
recognised as comparable in children with mild and
severe asthma [13,14].
HRQL assessment in children and adolescents with
asthma is an important tool to use if we wish to reduce the
current gap in understanding that exists between health
professionals' knowledge of the physiological correlates
of asthma and the individual burden of experiencing
asthma [3]. Parents do not perceive their children's HRQL
accurately, hence it is necessary to obtain the information
directly from the child [15].
Several instruments have been developed to evaluate
asthma-related quality of life. The Pediatric Asthma Qual-
ity of Life Questionnaire (PAQLQ) [16] is a 23-item meas-
ure for the age range 7–17 and it investigates three
domains: the symptoms, the limitations in activity and
the emotional function. Its measurement properties were
evaluated in a study which involved 52 children with a
wide range of asthma severity. It was recognized to have a
good construct validity, responsiveness to change over
time and test-retest reliability [3]. The PAQLQ has been
translated into several languages: its Italian version was
proposed in 1999 [12] and the cross-cultural adaptation
was made according to the proposed guidelines [17].
The aim of the present study was to evaluate the correla-
tion between the Italian, self-administered version of the
PAQLQ and the main clinical and instrumental indexes
that are normally included in the outpatients' routine vis-
its, and to investigate the possible role of the question-
naire during routine clinical practice visits of asthmatic
children.
Methods
Study plan
This prospective study included 52 consecutive children
(median age 11 years; range 6–17; 40 males and 12
females), affected by allergic asthma and referred to the
Allergology Outpatient Clinic of the Pediatric Department
of our hospital. Out of the total number, 23 (44%) were
found to be affected by seasonal type asthma, related to
symptoms appearance during spring time, while the
remaining 29 (56%) had perennial asthma, unrelated to
specific periods. Each child had a comprehensive evalua-
tion at his/her first visit which included: a) anamnestic
recordings and full physical inspection; b) spirometric
assessment of lung function; c) HRQL assessment, by
means of the PAQLQ; d) asthma severity assessment; e)
asthma control assessment. A follow-up visit was decided
depending on the child's type of asthma: children with
perennial asthma had a second evaluation after 6 months
if their health status was normal, and after 1 month if they
were not controlled or if their spirometry was altered; chil-
dren with seasonal asthma attacks, who had been
included before springtime, were examined again during
the spring.
Asthma control evaluation
For the assessment of asthma control, long-term treat-
ment objectives identified by the GINA working group
[18] were adopted. The definition of asthma control was
derived from these goals, as suggested by Bateman [19]
and by the Joint Task Force on Practice Parameters [20]. A
child was considered either under control or not under
control in the two weeks before the visit according to the
following parameters: no night-time or early morning
awakening due to asthma; no emergency hospital visits;
no exacerbations; no treatment-related adverse effects
causing a change in asthma therapy; no more than two
days with symptoms (cough, wheezing, chest tightness,
dyspnea); use of β2agonist reliever medications for no
more than two days.BMC Pediatrics 2009, 9:30 http://www.biomedcentral.com/1471-2431/9/30
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Spirometry
Lung function was assessed by means of a spirometric
analysis (Multispiro SA/100 Spirometer, Medical Equip-
ment Designs, Laguna Hills, CA). At spirometry, the fol-
lowing parameters were evaluated: forced vital capacity
(FVC); forced expiratory volume at the first second (FEV1);
percent ratio FEV1/FVC; forced expiratory flow between
25% and 75% of vital capacity (FEF25–75).
Asthma severity
Asthma severity was assessed according to the GINA
guidelines (Updated 2005) [21], thus divided into four
levels: intermittent, mild persistent, moderate persistent
and severe persistent.
Quality of life
HRQL was assessed by means of the Italian, self-adminis-
tered version of the PAQLQ [12], which includes 23 ques-
tions, further grouped into 3 domains:
1. symptoms: questions 1, 3, 5, 7, 9, 11, 13, 15, 17, 20;
2. activity limitations: questions 16, 19, 21, 22, 23;
3. emotional function: questions 2, 4, 6, 8, 10, 12, 14,
18.
After receiving exhaustive explanations on questions and
answering modalities, the children themselves filled out
the questionnaire during both visits, being blinded to
replies given at the first visit. For each child, the overall
score was calculated as the mean of scores obtained for
each single question. The scores ranged from 1 to 7, 1
being the minimum and 7 the maximum. The same
approach was adopted for subgroups of questions. Differ-
ences in the PAQLQ score ≥ 0.5 were considered as signif-
icant.
Informed consent
This study was only observational and did not interfere
with the clinical management of the patients, so it was not
submitted to the ethical committee for approval. How-
ever, both the parents and the patients were informed that
the questionnaire was proposed in an experimentational
manner; they were given the questionnaire only after
obtaining an informed consent.
Statistical analysis
The Kruskall Wallis test was used to compare the scores of
the PAQLQ in five subgroups of patients, split into quin-
tiles (the first group had FEV1 lower than the 20th percen-
tile, the second between the 20th and 40th percentile, the
third between the 40th and the 60th percentile, the fourth
between the 60th and 80th percentile and the fifth higher
than the 80th percentile). This approach is consistent with
the small population sample (n = 52) and its non-gaus-
sian value distribution. Mann-Whitney test was used to
evaluate possible differences between non-paired groups
and Wilcoxon test for paired data at t0 and at t1. Statistical
analysis was carried out by means of SPSS 16 for Windows
and Study Size Trial 1.08. Results were deemed statisti-
cally significant for a p ≤ 0.05.
Results
Population characteristics, asthma severity and control, 
PAQLQ percentiles
The main clinical characteristics of our population are
shown in Table 1.
Table 2 summarizes the main parameters considered in
the study.
Understanding of the PAQLQ
Children had an overall good understanding of the
PAQLQ. The main comprehension problems arose con-
cerning the concept of "last week", which was not always
clear for the youngest patients (ages 6, 7 or 8 years). For
the younger patients, a longer explanation and some kind
of assistance by a doctor or nurse was needed, but no help
was given by the parents in the replies. In reality the study
group included only one child aged 6 years (already going
to school) and three children aged 7. Despite the fact that,
after exhaustive explanation, they all expressed a good
understanding, it could be argued that these factors may
cause some biases in the completion of the self-adminis-
tered version of the questionnaire.
Evolution of the PAQLQ score and changes in the other 
parameters between the two visits
Neither Wilcoxon signed rank test nor Student paired test
were s.s. for any difference between time 0 and time 1.
No s.s. difference in asthma control but a significant dif-
ference in asthma severity evaluation (p < 0.01) was iden-
tified at Mc Nemar chi square owing to the worsening of
13 patients: 8 passed from class 1 to class 2 (7 patients)
and one of them passed to class 3; 4 patients passed from
Table 1: Characteristics of the 52 children, median age 11 years 
(range 6–17). ICS: inhaled corticosteroids. Other medications: 
leukotriene modifiers, chromones, antihistamines.
Sex Males n4 07 7 %
Females n1 22 3 %
seasonality of asthma Perennial n2 95 6 %
spring-time n2 34 4 %
controller medications ICS n4 28 1 %
other medications n2 44 6 %
ICS or other medications n4 68 9 %
exercise-induced asthma n2 75 2 %
Comorbidities Rhinoconjunctivitis n3 46 5 %
present Atopic Eczema n9 1 7 %
past Atopic Eczema n2 03 9 %BMC Pediatrics 2009, 9:30 http://www.biomedcentral.com/1471-2431/9/30
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class 2 to class 3 and 1 patient passed from class 3 to class
4. All the other patients were unvaried.
Regarding the medications used by our population, 15
patients (29%) needed to use salbutamol for asthma
attacks between the two visits; most of the patients (80%)
also needed steroid courses, either as continuous therapy
or as needed.
Differences in HRQL between t0 and t1 and correlation 
with asthma control and asthma severity
No significant improvement or worsening in HRQL
between the two examinations was identified in our pop-
ulation with the Wilcoxon test (19 patients had a higher
score, 29 a lower one and 4 had the same result); spiro-
metric indices did not change either. On the other hand,
some modifications between the first and the second visit
were identified in asthma severity and control: at the sec-
ond visit the percentage of moderate and severe persistent
asthma is higher (p < 0.02) and a higher number of chil-
dren are not under control (but this difference is not s.s.).
Results of the Mann-Whitney U test showed a significant
difference between asthma control and the PAQLQ score
both at the first (p < 0.01) and at the second visit (p <
0.001): children with a good control of symptoms have a
better HRQL, as plotted in Figure 1. The same test showed
that patients affected by seasonal-type asthma at the first
visit had a better HRQL than those affected by non-sea-
sonal-type asthma (p ≤ 0.05); this difference was no
longer present at the second visit. At the first visit, patients
with spring-related symptoms had a better control than
children with non-seasonal-type asthma (p ≤ 0.01),
whereas data from the second visit do not show this dif-
ference.
Kruskall Wallis test was s.s. (p < 0.04) for a decrease in the
PAQLQ score from the first to the fourth class of asthma
Table 2: Summary of data in the two steps of the study.
Data at t0 Data at t1
Clinical
evaluations
N
(%)
N
(%)
Asthma severity
12 9
(55,8%)
21
(40,4%)
21 5
(28,8%)
18
(34,6%)
36
(11,5%)
10
(19,2%)
42
(3,8%)
3
(5,8%)
Under-control asthma 39
(75%)
32
(61,5%)
Quantitative measures Mean
(standard deviation)
50th P2 5 th P–75th P Mean (Standard deviation) 50th P2 5 th P–75th P
FVC 105,66
(15,36)
106,60 97,85–116,15 106,21
(12,91)
107,15 99,15–113,60
FEV1 100,10
(18,47)
101,90 94,00–112,45 100,95
(17,28)
102,30 90,55–113,15
FEV1/FVC 94,10
(12,16)
97,55 88,40–102,75 94,11
(11,37)
96,35 88,60–102,55
FEF25–75 94,98
(32,29)
98,85 71,90–120,45 94,64
(34,58)
97,40 68,50–125,10
PAQLQ total score 6,09
(1,04)
6,48 5,85–6,85 6,24
(0,88)
6,41 5,85–6,91
PAQLQ-symptoms 6,79
(1,33)
7,26 5,98–7,81 6,98
(1,12)
7,34 6,46–7,84
PAQLQ-activity limitation 4,77
(1,02)
4,88 4,16–5,68 4,87
(0,94)
5,08 4,08–5,88
PAQLQ-emotional function 5,75
(0,92)
6,23 5,86–6,23 5,90
(0,78)
6,23 5,86–6,23
Asthma severity 1 = Intermittent, 2 = Mild persistent, 3 = Moderate persistent, 4 = Severe persistent.BMC Pediatrics 2009, 9:30 http://www.biomedcentral.com/1471-2431/9/30
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severity, both at time 0 and at time 1 (Figure 2). This
means that HRQL is worse when the disease is more
severe, as could be expected.
To analyze better the relationship between the PAQLQ
and lung function, the PAQLQ score was evaluated in 5
subgroups of patients who were divided according to their
FEV1 (Figure 3). The graphs suggest a better compliance of
the children towards completion of the questionnaire at
t1. Moreover, it seems that the PAQLQ does not discrimi-
nate HRQL in patients with a good lung function: figure 3
shows a plateau of the results for patients' FEV1 over the
60th percentile.
Discussion
Our results confirm the link between the Italian version of
the PAQLQ and the main clinical and functional parame-
ters which are normally evaluated during follow-up visits
of asthmatic school-aged children. Several translated ver-
sions of the questionnaire exist in other languages, and
they are all consistent with our results.
Differences in HRQL between controlled and uncontrolled patients at the first visit (p < 0.01) and at the second visit (p <  0.001) Figure 1
Differences in HRQL between controlled and uncontrolled patients at the first visit (p < 0.01) and at the sec-
ond visit (p < 0.001).
Decrease in the PAQLQ score in patients with increasing asthma severity at time 0 and at time 1 (p < 0,04 at time 0 and p <  0,03 at time 1) Figure 2
Decrease in the PAQLQ score in patients with increasing asthma severity at time 0 and at time 1 (p < 0,04 at 
time 0 and p < 0,03 at time 1).BMC Pediatrics 2009, 9:30 http://www.biomedcentral.com/1471-2431/9/30
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A study conducted on 52 Canadian children aged 7 to 17
demonstrated that the PAQLQ has an excellent respon-
siveness and a high level of reliability [16]. The question-
naire showed good levels of both longitudinal and cross-
sectional correlations with the conventional asthma indi-
ces and with general quality of life. However, no correla-
tions were found between the questionnaire's score and
FEV1 percent of predicted.
A study that examined the validity of the Swedish version
of the PAQLQ was published in the year 2000 [22]. Sixty-
one 7-to-9-year-old children were enrolled. Their symp-
toms score, percentage of expected peak flow rate and
physician's grading of asthma severity correlated signifi-
cantly with the PAQLQ scores. The instrument was found
to be easy to administer, well accepted by the children and
had an acceptable internal consistency.
Similar results were obtained in the validation of the
Spanish cross-cultural adaptation of the PAQLQ [23],
which involved 99 children. Correlations between the
scores of the PAQLQ, of an asthma control instrument, of
a general health questionnaire and lung function indexes
were moderate. The Spanish version of the PAQLQ, com-
pared to the original, showed a similar internal consist-
ency, reliability, validity and sensitivity to clinical
changes.
In 2005 a study was published which validated the Dutch
version of the PAQLQ [24]. 238 children aged 6 to 18
years were evaluated. Correlations between the question-
naire's score and symptom diary scores indicated ade-
quate psychometric properties, excellent responsiveness
and supported the longitudinal and cross-sectional con-
struct validity. No lung function parameters were taken
into account.
Our results are consistent with those of the above studies:
the PAQLQ correlates with the assessment of asthma con-
trol given by the clinician. These results indicate that the
Italian version of the PAQLQ is a valid instrument that
can be used in daily practice when asthmatic children are
evaluated. However, the PAQLQ seems to be unable to
discriminate HRQL in children with good lung function,
suggesting that a more sensitive instrument might be
needed in these cases.
The fact that HRQL is worse in children with lower asthma
control may seem obvious. However, administration of
the questionnaire allowed us to note that the main
domains which are impaired in asthmatic children are the
symptoms and the activity limitations. Children and adoles-
cents are often worried about asthma attacks, and cough
and chest tightness might be a cause of concern for them.
They also seem to suffer from limitations in those activi-
ties that might exacerbate an asthma attack and make
them feel uncomfortable.
A limitation of this study is that it does not take into con-
sideration the fraction of exhaled nitric oxide. This is a
new tool for the diagnosis and monitoring of bronchial
asthma which allows airways inflammation to be meas-
ured. It could be interesting, in future studies, to correlate
the PAQLQ to the levels of exhaled nitric oxide.
Another limitation of this study concerns the difficulties
of some of the younger children in grasping the concept
of "last week"; this might, in fact, cause some biases in the
Median HRQL score trend in function of FEV1 values at t0 (on the left) and at t1 (on the right) Figure 3
Median HRQL score trend in function of FEV1 values at t0 (on the left) and at t1 (on the right). Boxes are delimited 
by the 25th percentile (at the bottom) and 75th percentile (top) of HRQL.BMC Pediatrics 2009, 9:30 http://www.biomedcentral.com/1471-2431/9/30
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completion of the self-administered version of the
PAQLQ.
Moreover, it would have been interesting to compare the
HRQL of the caregivers, and to investigate their expecta-
tions and priorities concerning asthma, as was recently
done by Wu and colleagues [25].
In 2002 a study was conducted by Williams & Williams
[26] in order to evaluate the usefulness and feasibility of
asthma-specific questionnaires in children during routine
clinical practice. They investigated correlations between
the PAQLQ score, the score of a caregiver's quality of life
questionnaire and the assessment of control given by the
clinician in a group of 42 children 7 to 17-years old. No
correlations were found between the aforementioned
parameters, thus possibly affecting treatment planning
with the family. When no ideal single parameter is availa-
ble to monitor asthma control adequately, the adminis-
tration of a quality of life instrument is an important and
quick-to-administer aid to the clinical activity which can
supplement symptom reports, objective measures and
clinical assessment of asthma control and severity. The
same conclusion was reached by Reichenberg & Broberg
in 2003 [27], who found correlations between the
PAQLQ, caregiver's quality of life, peak flow rate and the
parents' reports of child asthma symptoms in a group of
71 7-to-9-year-olds with asthma. Re-administration of the
questionnaire at each follow-up visit could be a useful
way to keep the child's HRQL monitored over time.
Recently, the use of an electronic version of the PAQLQ
was proposed, and it showed promising results for use in
routine asthma care [28].
Conclusion
Interpretation of HRQL data is still debated. Today,
patients are much more closely involved in understanding
their condition, identifying their own needs, and working
with the clinician in developing a treatment plan [29].
Only three studies, to the best of our knowledge, have
used factor analysis to determine whether asthma health
status is a homogeneous or heterogeneous construct [30-
32]; they all identified that asthma is a composite condi-
tion. Two of these papers [31,32] include HRQL evalua-
tion in the analysis, and they identified that HRQL is a
distinct component of the asthma health status. Although
it is interesting to think of HRQL as a separate facet of this
condition, further analysis is necessary to fully understand
the role of HRQL assessment in routine practice when
dealing with asthmatic children.
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